产品编号 :
Cas No. :
CAS No. |
1431697-78-7 |
|---|---|
中文名称 |
2-((1R,2S)-1-氨基-2-甲基-4-苯基丁基)-N-(3-氟-4-(三氟甲基)苯基)噻唑-5-甲酰胺盐酸盐 |
英文名称 |
CAL-130 HCl |
别名 |
(S)-2-(1-((2-aMino-9H-purin-6-yl)aMino)ethyl)-5-Methyl-3-(o-tolyl)quinazolin-4(3H)-one hydrochloride;CAL-130 (Hydrochloride);2-[(1S)-1-[(2-Amino-9H-purin-6-yl)amino]ethyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone hydrochloride (1:1);CAL-130 HCl;CAL130 Hydrochloride,CAL 130 Hydrochloride |
标准英文名 |
(S)-2-(1-((2-amino-7H-purin-6-yl)amino)ethyl)-5-methyl-3-(o-tolyl)quinazolin-4(3H)-one hydrochloride |
MDL No. |
MFCD25372043 |
分子式 |
C23H23ClN8O |
分子量 |
462.95 |
精确分子量 |
462.17 |
SMILES |
O=C1N(C2=CC=CC=C2C)C([C@H](C)NC3=C4N=CNC4=NC(N)=N3)=NC5=C1C(C)=CC=C5.[H]Cl |
标准SMILES |
Cl.C[C@H](NC1N=C(N)N=C2NC=NC2=1)C1=NC2C=CC=C(C)C=2C(=O)N1C1=CC=CC=C1C |
用途 |
CAL-130 Hydrochloride is a potent and selective inhibitor of PI3Kδ and PI3Kγ, with IC50 values of 1.3 nM and 6.1 nM, respectively. It shows significantly lower activity against PI3Kα (IC50 = 115 nM) and PI3Kβ (IC50 = 56 nM), and does not inhibit other critical intracellular signaling pathways such as p38 MAPK or insulin receptor tyrosine kinase. It is used in research to investigate the therapeutic potential of dual PI3Kγ/δ inhibition, particularly in the treatment of T-cell acute lymphoblastic leukemia (T-ALL). In vivo studies demonstrate that CAL-130 significantly extends median survival in a murine model of T-ALL, highlighting its potential as a targeted anticancer agent. |
InChIKey |
XEUIGTXAJSGCRB-UQKRIMTDSA-N |
|
|
评论 |
|---|